Wolverine Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-590
| Closed | -$139K | – | 1130 |
|
|
2024
Q4 | $139K | Hold |
590
| – | – | ﹤0.01% | 707 |
|
|
2024
Q3 | $162K | Hold |
590
| – | – | ﹤0.01% | 675 |
|
|
2024
Q2 | $143K | Hold |
590
| – | – | ﹤0.01% | 680 |
|
|
2024
Q1 | $88.2K | Buy |
+590
| New | +$88.2K | ﹤0.01% | 712 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 1348 |
|
|
2021
Q2 | – | Sell |
-406
| Closed | -$57K | – | 1872 |
|
|
2021
Q1 | $57K | Buy |
406
+393
| +3,023% | +$55.2K | ﹤0.01% | 1355 |
|
|
2020
Q4 | $1K | Buy |
+13
| New | +$1K | ﹤0.01% | 1266 |
|
|
2020
Q3 | – | Sell |
-13
| Closed | -$1K | – | 1234 |
|
|
2020
Q2 | $1K | Buy |
+13
| New | +$1K | ﹤0.01% | 1170 |
|
|
2018
Q4 | – | Sell |
-12,455
| Closed | -$1.09M | – | 1079 |
|
|
2018
Q3 | $1.09M | Buy |
+12,455
| New | +$1.09M | 0.01% | 485 |
|